Trudy Oliver Tracks a Deadly, Shapeshifting Tumor : comparem

Trudy Oliver, PhD, studies a type of cancer that has a 5-year overall survival rate of just 7%. Its biological drivers are different from most other cancers, so it’s harder to develop targeted treatments. On top of that, research into this tumor is under-funded.

Related Keywords

University Of Utah , Utah , United States , Trudy Oliver , Jim Rogalski , Jack Finlay , Bryony Hawgood , Angela Spivey , Tyler Jacks , Alex Boerner , Bradley Goldstein , Duke University School Of Medicine , Huntsman Cancer Institute , School Of Medicine Office Strategic Communications , National Institutes Of Health , Technology Scholar , Duke University School , Duke Science , Cancer Cell , Abbie Ireland , Collaborations Already , National Institutes ,